Search results
Results from the WOW.Com Content Network
In 2017, there was a rise in the number of dengue fever cases reported in the island country of Sri Lanka. The peak of the outbreak occurred during the mid-year monsoon season with more than 40,000 cases reported in July alone, far exceeding historical highs. By the end of the year, the total number of dengue cases had risen to 186,101. [1]
Dengue was first serologically confirmed in the country in 1962. A Chikungunya outbreak followed in 1965. In the early 1970s two type of dengue dominated in Sri Lanka: DENV-1 type1 and DENV-2 type 2. A total of 51 cases and 15 deaths were reported in 1965–1968. From 1989 onward, dengue fever has become endemic in Sri Lanka. [4]
Dengue cases in NJ. Of New Jersey's 41 cases, Bergen, Essex and Middlesex counties have had the most in the state in 2024, according to the New Jersey Department of Health's vector-borne diseases ...
In Sri Lanka, there were 180,000 reported cases in 2017. [103] The majority of cases being reported from the Western province. The highest numbers of dengue cases were reported during the 20 week of 2017. [104] Sri Lankan health authorities warned that the country was facing a dengue epidemic with at least 301 patients dead. [105]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
2017 dengue outbreak in Sri Lanka: 2017 Sri Lanka: Dengue fever: 440 [293] 2018 Nipah virus outbreak in Kerala: 2018 India Nipah virus infection: 17 [294] Kivu Ebola epidemic: 2018–2020 Democratic Republic of the Congo and Uganda: Ebola: 2,280 [295] [296] [297] 2018 NDM-CRE outbreak in Italy 2018–2019 Italy
Flu vaccines used during the flu in 2009. This is a list of vaccine-related topics.. A vaccine is a biological preparation that improves immunity to a particular disease.A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins.
The successor to PDVI, the Dengue Vaccine Initiative was an IVI-led consortium with the World Health Organization, the Sabin Vaccine Institute, the Initiative for Vaccine Research (IVR), and the International Vaccine Access Center (IVAC) at Johns Hopkins University. DVI continued the work of PDVI and focused on laying the groundwork for dengue ...